Incyte (INCY) Gross Margin (2012 - 2026)
Incyte's (INCY) quarterly Gross Margin came in at 93.73% in Q2 2026, up 21.0% YoY from 77.46% in Q2 2025, and up 2.12% on a QoQ basis from 91.79% in Q1 2026.
Powered by 
Analysis
Incyte (INCY) Gross Margin (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Gross Margin data on file, last reported at 93.73% in Q2 2026.
- Quarterly Gross Margin rose 21.0% year-over-year to 93.73% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 92.62% (down 26.0% YoY) and the FY2025 annual result came in at 92.76%, up 12.0% from the prior year.
- Gross Margin grew to 93.73% in Q2 2026, from 91.79% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.44% in Q2 2022 to a low of 91.79% in Q1 2026.
- A 5-year average of 93.08% and a median of 93.06% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 173 bps — and 2025, when it soared 86 bps.
- Tracing INCY's Gross Margin over 5 years: stood at 93.62% in 2022, then declined by 1 bps to 93.12% in 2023, then retreated by 1 bps to 92.49% in 2024, then slipped by 1 bps to 91.96% in 2025, then advanced by 2 bps to 93.73% in 2026.
- The last three Gross Margin figures came in at 93.73% (Q2 2026), 91.79% (Q1 2026), and 91.96% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | - |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 84.20% |
| 10 | Incyte | 25.59 Bn | 21.06 Bn | 1.57 Bn | 93.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.73% |
| Mar 31, 2026 | 91.79% |
| Dec 31, 2025 | 91.96% |
| Sep 30, 2025 | 92.75% |
| Jun 30, 2025 | 93.52% |
| Mar 31, 2025 | 93.05% |
| Dec 31, 2024 | 92.49% |
| Sep 30, 2024 | 92.44% |
| Jun 30, 2024 | 92.66% |
| Mar 31, 2024 | 93.08% |
| Dec 31, 2023 | 93.12% |
| Sep 30, 2023 | 93.46% |
| Jun 30, 2023 | 92.84% |
| Mar 31, 2023 | 92.97% |
| Dec 31, 2022 | 93.62% |
| Sep 30, 2022 | 93.37% |
| Jun 30, 2022 | 94.44% |
| Mar 31, 2022 | 94.19% |
| Dec 31, 2021 | 94.92% |
| Sep 30, 2021 | 95.10% |